SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-292919
Filing Date
2019-11-15
Accepted
2019-11-15 09:07:02
Documents
5
Period of Report
2019-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836381d8k.htm 8-K 24943
2 EX-99.1 d836381dex991.htm EX-99.1 13136
3 EX-99.2 d836381dex992.htm EX-99.2 11769
4 GRAPHIC g836381g1115034555215.jpg GRAPHIC 3637
5 GRAPHIC g836381g1115034606650.jpg GRAPHIC 3637
  Complete submission text file 0001193125-19-292919.txt   61406
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 191222610
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences